How breast cancer is staged
- Medical Review: Pallav K. Mehta, MD
The stage of a breast cancer describes the extent of the cancer in your breast and in the body. When doctors stage the breast cancer, they look at these factors:
- How far the cancer has spread, using a system called TNM (tumor, lymph nodes, metastasis):
- The size of the tumor (T)
- Whether lymph nodes near the breast contain breast cancer (N)
- Whether the breast cancer has spread from the breast to other parts of the body (M)
- Characteristics of the cancer cells that show how the cancer is behaving:
- Estrogen receptor (ER) status: Whether the cancer has proteins to which the hormone estrogen attaches
- Progesterone receptor (PR) status: Whether the cancer has proteins that attach to the hormone progesterone
- HER2 status: Whether the cancer is making too much of a protein known as HER2
- Grade (G): How similar the cancer cells look to normal cells
In some cases, Oncotype Dx score, which measures the risk of recurrence, is part of staging.
Breast cancer stages can be clinical or pathological. The clinical stage is based on a physical exam by your doctor and any scans, including mammogram, ultrasound, and MRI, that you have had. Pathologic stage is based on what is found during surgery to remove the cancer. Pathologic stage is more precise, but clinical stage may be use to guide treatments given before surgery.
Stage is one piece of information doctors use to understand how well a treatment might work. Stage, along with other factors including advances in treatment, is also used to estimate survival rates.
Stage 0
Stage 0 breast cancer is noninvasive. This means the cancer cells are contained inside of the ducts of the breast and no cancer cells can be seen breaking through to surrounding breast tissue. Ductal carcinoma in situ, or DCIS, is stage 0 breast cancer.
Stage I
Stage I breast cancers are invasive. This means that the cancer has broken through the ducts or lobules into surrounding breast tissue. Stage I breast cancers are 2 centimeters or smaller in size. Usually, these cancers have not traveled to the lymph nodes.
Stage I breast cancer falls into two groups: stages IA and IB.
Stage IA breast cancers usually have the following characteristics:
- The tumor is 2 centimeters (about the size of a peanut without the shell) or smaller. This can include very small tumors of less than 1 millimeter (microinvasive breast cancer).
- There is no cancer in the lymph nodes.
- The cancer has not spread beyond the breast to any other organs.
Stage IB breast cancers include these situations:
- There is no evidence of a breast tumor, but there are small areas of cancer in the underarm (axillary) lymph nodes measuring at least 0.2 millimeters but are no larger than 2 millimeters in size, called micrometastasis.
- There is a breast tumor that is 2 centimeters or less across, including as small as 1 millimeter or less (microinvasive breast cancer), and there are small areas of cancer in the axillary lymph nodes (micrometastasis) measuring at least 0.2 millimeters but are no larger than 2 millimeters in size.
- In all cases of stage IB breast cancer, the cancer has not spread to any other organs
Hormone receptor status, HER2 status, and cancer grade are also factors in determining whether a cancer is stage I.
Stage II
Stage II breast cancers fall into two groups: IIA and IIB.
Stage IIA includes these situations:
- There isn’t any evidence of a breast tumor, but there is cancer in one to three axillary lymph nodes or internal mammary lymph nodes (near the breastbone, identified with sentinel lymph node biopsy).
- The tumor is 2 centimeters or less across and there is cancer in one to three axillary lymph nodes and/or internal mammary lymph nodes.
- The tumor is between 2 and 5 centimeters across and there is no cancer in the lymph nodes.
- In all cases, cancer has not spread beyond the breast to any other organs.
Stage IIB includes these situations:
- The tumor is between 2 and 5 centimeters across and there is cancer in one to three axillary lymph nodes or internal mammary lymph nodes (near the breastbone, sometimes identified with sentinel node biopsy).
- The tumor is more than 5 centimeters across and there is no cancer in the lymph nodes, or a tiny amount of cancer has been detected in lymph nodes at a size smaller than 0.2 millimeters.
- In all cases, cancer has not spread beyond the breast to any other organs.
Hormone receptor status, HER2 status, and cancer grade are also factors in determining whether a cancer is stage II.
Stage III
Stage III breast cancers fall into three groups: stages IIIA, IIIB, and IIIC.
Stage IIIA includes these situations:
- There is no evidence of a tumor, or there is a tumor of any size and cancer is found in four to nine axillary lymph nodes, or the cancer has caused the internal mammary lymph nodes near the breastbone to become enlarged.
- The tumor is larger than 5 centimeters across and there is cancer in one to three axillary lymph nodes or internal mammary lymph nodes near the breastbone, found during a sentinel node biopsy.
- In all cases, the cancer has not spread to distant organs such as the bones, lungs, or liver.
Stage IIIB includes these situations:
- The tumor may be of any size that has grown into the skin or the chest wall.
- Cancer may be found in 0 to 9 axillary lymph nodes.
- Cancer may have one or more enlarged internal mammary lymph nodes near the breastbone.
- The breast cancer may also be inflammatory. Inflammatory breast cancer is breast cancer that has certain physical signs that appear and worsen quickly, these can include breast redness, warmth, swelling, or an “orange peel” look on the breast skin. Inflammatory breast cancer usually does not form a lump and may not be found in a mammogram. Inflammatory breast cancers can be hormone receptor positive, HER2 positive, or triple-negative.
- In all cases, the cancer has not spread to distant organs such as bones, lungs, or liver.
Stage IIIC breast cancers may have a tumor of any size or no tumor at all, when cancer is found:
- In 10 or more axillary lymph nodes in any number of internal mammary lymph nodes near the breastbone
- In a combination of axillary and internal mammary lymph nodes
- In supraclavicular lymph nodes (lymph nodes near the collarbone)
- To be inflammatory breast cancer. This means it has certain physical signs that appear and worsen quickly, these can include breast redness, warmth, swelling, or an “orange peel” look on the breast skin. Inflammatory breast cancer usually does not form a lump and may not be found in a mammogram. Inflammatory breast cancers will also be either hormone receptor-positive, HER2-positive, or triple negative.
- To have not spread to distant organs such as bones, lungs, or liver.
Hormone receptor status, HER2 status, and cancer grade are also factors in determining whether a cancer is stage III.
Stage IV
Stage IV or metastatic breast cancer is invasive cancer that has spread beyond the breast to other parts of the body. Common locations of spread can include
- Lymph nodes in distant parts of the body
- The chest wall
- The bones, liver, lungs, or brain
Stage IV breast cancer is often a recurrence, or the return of a previous breast cancer. If stage IV is the very first diagnosis of breast cancer, it’s often called de novo (“starting from the beginning”) metastatic breast cancer.
Advanced breast cancer vs. metastatic breast cancer
You might hear stage IV breast cancer referred to as advanced or metastatic. It’s important to know that “advanced” can mean stage IV breast cancer, but it can also refer to “locally advanced” breast cancer. Locally advanced breast cancer has spread to areas near the breast, including lymph nodes, skin, and/or the chest wall, but not to other locations of the body. Inflammatory breast cancer can be locally advanced or metastatic.
The TNM system
After you receive a breast cancer diagnosis, your doctor may ask for radiology tests, more biopsies, a physical exam and more details from you about your symptoms. With all this information, your doctor will assign a stage to the breast cancer using the American Joint Committee on Cancer TNM system.
The TNM system is the most widely used systems to describe the stages of breast cancer. Most cancer care teams use the TNM system as a standard way to describe how far the cancer has spread. Doctors use the TNM stage of the cancer to make decisions about which treatments are best for you.
Each letter in the TNM system is assigned a number to show the size of the original tumor and how far the cancer has spread. Here, we’ll walk you through what it all means.
T: Tumor
T stands for tumor. The T stage is determined by the size of the tumor and whether it has affected the skin over the breast or the muscle beneath the breast.
T includes these categories for breast cancer:
- TX means the size of the tumor can’t be determined
- T0 means there is no evidence of the primary tumor
- Tis means the cancer is “in situ” (DCIS, LCIS, or Paget disease of the breast with no tumor mass)
- T1 tumors are 2 centimeters or less across
- T2 tumors are larger than 2 centimeters but less than 5 centimeters across
- T3 tumors are larger than 5 centimeters across
- T4 cancers have spread into the chest wall or skin, or are inflammatory breast cancer
N: Lymph nodes
N stands for lymph nodes. The N stage is determined either by:
- The number of lymph nodes in the armpit, called axillary nodes, that have cancer
- The number of nodes near the breastbone in the center of the chest, called internal mammary nodes, that have cancer
- The number of nodes in the base of the neck near the collarbone, called supraclavicular nodes, that have cancer
N includes these categories for breast cancer:
- NX means that it can’t be determined whether the cancer is in nearby lymph nodes
- N0 means cancer has not traveled to nearby lymph nodes
- N1 means cancer is in one to three armpit lymph nodes, in lymph nodes near the breastbone, or in both
- N2 means cancer is in four to nine armpit lymph nodes, in the lymph nodes near the breastbone, or in both
- N3 means cancer is in 10 or more armpit lymph nodes, or in the lymph nodes near the collarbone, or in lymph nodes near the breastbone, or in some combination of these
M: Metastasis
M stands for metastasis. The M stage is determined by whether the cancer has traveled from your breast and nearby lymph nodes to another area in your body.
M includes these categories for breast cancer:
- MX means it can’t be determined whether or not the cancer has metastasized
- M0 means the cancer hasn’t metastasized
- M1 means the cancer has metastasized to another part of the body, such as the bones, lungs, liver, or brain
Stay connected
Sign up to receive emotional support, medical insight, personal stories, and more, delivered to your inbox weekly.
- 3-dimensional radiation therapy
- 4-hydroxytamoxifen
- ablation
- abnormal
- Abraxane
- absolute risk
- AC regimen
- AC-T regimen
- AC-T-T regimen
- AC-Taxol regimen
- AC-TH regimen
- accelerated partial-breast irradiation
- action study
- acupoint
- acupressure
- acupuncture
- acupuncture needle
- acupuncture point
- acupuncture point injection
- acupuncturist
- acustimulation
- acute
- acute pain
- adenocarcinoma
- adenopathy
- adenosis
- adjunct agent
- adjunct therapy
- adjunctive therapy
- adjuvant therapy
- advance directive
- advanced practice nurse
- adverse effect
- aerobic exercise
- agent study
- aggravating factor
- aggressive
- AJCC staging system
- Alkeran
- alkylating agent
- Allegra
- allopathic medicine
- alopecia
- amifostine
- aminoglutethimide
- amitriptyline
- anabolic steroid
- analgesic
- anaplastic
- anastrozole
- ancillary test
- anemia
- anesthesia
- anesthesiologist
- angiogenesis
- angiogenesis inhibitor
- antagonist
- anthracycline
- anti-anxiety medicine
- anti-idiotype vaccine
- anti-inflammatory
- antibody-dependent cellular cytotoxicity
- antibody therapy
- anticachexia
- anticancer antibiotic
- anticancer therapy
- anticonvulsant
- antidepressant
- antiemetic
- antiestrogen
- antifolate
- antigen-presenting cell vaccine
- antihormone therapy
- antimetabolite
- antimitotic agent
- antineoplastic
- antitumor
- anxiety
- anxiolytic
- Anzemet
- APN
- apocrine gland
- apoptosis
- aprepitant
- areola
- Aromasin
- aromatase inhibitor
- aromatherapy
- arthralgia
- ascites
- aspirate
- aspiration
- assay
- asthenia
- asymptomatic
- atypia
- atypical ductal hyperplasia
- atypical hyperplasia
- atypical lobular hyperplasia
- avoidance
- axillary lymph node
- axillary lymph node dissection
- BAK gel
- balloon catheter radiation
- baseline
- behavior modification
- best practice
- BI-RADS
- Biafine cream
- bias
- bilateral
- bilateral breast cancer
- bilateral prophylactic mastectomy
- bilateral salpingo-oophorectomy
- biofeedback
- biologic
- biopsy
- biopsy specimen
- biotherapy
- bisphosphonate
- bisphosphonate-associated osteonecrosis
- blinded study
- blood-brain barrier
- blood-brain barrier disruption
- blood cell count
- blood chemistry study
- board certified oncology pharmacy specialist
- body image
- body mass index
- bolus dose
- bone density
- bone metastasis
- bone mineral density scan
- bone scan
- bone-seeking radioisotope
- brachytherapy
- brain metastasis
- BRCA1
- BRCA2
- BRCAPro
- breast carcinoma in situ
- breast-conserving surgery
- breast density
- breast duct
- breast duct endoscopy
- breast lobe
- breast lobule
- breast reconstruction
- breast self-exam
- Brief Pain Inventory
- cachexia
- CAF regimen
- calcification
- cancer vaccine
- candidiasis
- capecitabine
- carboplatin
- carcinogen
- carcinoma
- carcinoma in situ
- carcinomatous meningitis
- carcinosis
- carcinostatic
- cardiotoxicity
- caregiver
- carmustine
- case-control study
- case report
- case series
- CAT scan
- CBC
- cell
- cell-cycle regulation
- cell proliferation
- central nervous system
- central nervous system metastasis
- central nervous system prophylaxis
- central venous access catheter
- cetuximab
- cevimeline
- chaplain
- charged-particle radiation therapy
- chemoembolization
- chemoimmunotherapy
- chemoprevention
- chemoprevention study
- chemoprotective
- chemoradiation
- chemosensitivity
- chemosensitivity assay
- chemosensitizer
- chemotherapeutic agent
- chemotherapy
- chest wall
- chest X-ray
- Chinese meridian theory
- chronic
- chronic pain
- cisplatin
- Claus model
- clergy
- clinical
- clinical breast exam
- clinical practice guidelines
- clinical researcher
- clinical resistance
- clinical series
- clinical stage
- clinical staging
- clinical study
- clinical trial
- clinician
- clodronate
- CMF regimen
- cognition
- cognitive behavior therapy
- cognitive therapy
- cohort
- cohort study
- coinsurance
- combination chemotherapy
- comedo carcinoma
- comfort care
- Coming Out
- Community Advisory Board
- comorbidity
- compassionate use trial
- complementary and alternative medicine
- complementary medicine
- complete metastasectomy
- complete remission
- complete response
- complex decongestive therapy
- compliance
- complication
- compression garment
- computed tomography scan
- concomitant
- concurrent therapy
- condition
- consolidation therapy
- constitutional acupuncture
- continuum of care
- contract research organization
- contraindication
- contralateral
- contrast material
- control group
- controlled clinical trial
- controlled study
- conventional medicine
- conventional therapy
- copayments
- cope
- coping skills
- core biopsy
- core needle biopsy
- corticosteroid
- counseling
- COX inhibitor
- cryoablation
- cryopreservation
- cryosurgery
- CT scan
- cultural competency
- cumulative dose
- cumulative exposure
- cure
- cutaneous
- cutaneous breast cancer
- cyclophosphamide
- cyclosporine
- CYP2D6 inhibitor
- cystosarcoma phyllodes
- cytopenia
- cytotoxic
- cytotoxic chemotherapy
- Cytoxan
- Data and Safety Monitoring Board
- DCIS
- de novo
- debulking
- deductible
- definitive surgery
- definitive treatment
- dehydration
- denosumab
- depression
- diagnosis
- diagnostic mammogram
- diagnostic procedure
- diagnostic technique
- diagnostic trial
- diameter
- diarrhea
- diaziquone
- DIEP flap
- dietary counseling
- dietary supplement
- dietitian
- differentiation
- diffuse
- digital mammography
- diphenhydramine
- discharge
- disease progression
- disease-specific survival rate
- distant cancer
- distant metastasis
- Distant recurrence
- distress
- DNR order
- docetaxel
- dolasetron
- dose
- dose-dense chemotherapy
- dose-dependent
- dose-limiting
- dose-rate
- double-blinded
- doxorubicin
- drain
- dronabinol
- droperidol
- drug interaction
- drug resistance
- drug therapy
- drug tolerance
- duct
- ductal carcinoma
- ductal carcinoma in situ
- ductal lavage
- duloxetine
- durable power of attorney
- dysfunction
- dysgeusia
- dyspepsia
- dyspnea
- early menopause
- early-stage breast cancer
- edema
- EEG biofeedback
- efficacy
- Eklund displacement views
- electroacupuncture
- electron beam
- eligibility criteria
- Ellence
- emesis
- emetic
- endocrine
- endocrine therapy
- endpoint
- energy healing
- enteral nutrition
- epidemiology
- epirubicin
- ER+
- ER-
- ER
- ER-PR-HER2/neu-
- eribulin mesylate
- erythema
- estradiol
- estrogen
- estrogen blocker
- estrogen receptor
- estrogen receptor-negative
- estrogen receptor-positive
- estrogen receptor test
- estrogen replacement therapy
- etanidazole
- etidronate
- everolimus
- Evista
- excision
- excisional biopsy
- exemestane
- expanded access trial
- experimental
- extranodal
- false-negative test result
- false-positive test result
- familial cancer
- family medical history
- Faslodex
- fast-neutron beam radiation
- fatigue
- FDA
- febrile neutropenia
- FEC regimen
- Femara
- fertility
- fexofenadine
- fibroadenoma
- fibrocystic breast changes
- fiducial marker
- film mammography
- fine-needle aspiration biopsy
- first-degree relative
- first-line therapy
- five-year survival rate
- fluorouracil
- fluoxetine
- FNA biopsy
- focal
- Food and Drug Administration
- Fosamax
- fractionation
- fulvestrant
- functional magnetic resonance imaging
- gadolinium
- Gail model
- gallium scan
- gamma irradiation
- Gamma Knife therapy
- gamma ray
- Gelclair
- gemcitabine
- gene
- gene expression profile
- gene therapy
- general anesthesia
- generalized anxiety disorder
- generic
- genetic
- genetic counseling
- genetic marker
- genetic marker of susceptibility
- genetic predisposition
- genetic profile
- genetic susceptibility
- genetic testing
- genetic testing
- genetics
- genome
- genome-wide association study
- genomic profile
- genomic test
- genomics
- gland
- Good Clinical Practice
- goserelin
- grade
- grading
- granisetron
- gross description
- Halaven
- hazard ratio
- healing touch
- Health Insurance Portability and Accountability Act
- healthcare provider
- healthcare proxy
- healthy control
- helical computed tomography
- HER2/neu
- Herceptin
- hereditary
- hereditary mutation
- heteronormative
- high-dose chemotherapy
- high-dose radiation
- high-energy proton therapy
- high grade
- high-risk cancer
- HIPPA
- histologic examination
- histology
- historic cohort study
- historical control subject
- homeopathic medicine
- hormonal therapy
- hormone
- hormone receptor
- hormone receptor test
- hormone replacement therapy
- hormone responsive
- hormone therapy
- hospice
- hot flash
- human epidermal growth factor receptor 2
- human participant protection regulations
- hydroxydaunorubicin
- hyperalimentation
- hypercalcemia
- hyperfractionated radiation therapy
- hyperfractionation
- hyperplasia
- hypersensitivity
- hypofractionated radiation therapy
- hypofractionation
- hypoxia
- ibandronate
- ibuprofen
- idiopathic
- image-guided radiation therapy
- imaging
- imaging procedure
- immune adjuvant
- immune function
- immune response
- immune system
- immune system tolerance
- immunization
- immunoassay
- immunocompromised
- immunodeficiency
- immunohistochemistry
- immunology
- immunomodulation
- immunosuppression
- immunotherapy
- implant
- implant displacement views
- implant radiation therapy
- implantable pump
- in network
- in situ
- incidence
- incision
- incisional biopsy
- indication
- indolent
- induction therapy
- infection
- infertile
- infertility
- infiltrating breast cancer
- infiltrating ductal carcinoma
- inflammation
- inflammatory breast cancer
- informed consent
- infusion
- ingestion
- inherited
- iniparib
- injection
- inoperable
- insomnia
- Institutional Review Board
- intensification therapy
- intensity-modulated radiation therapy
- interfering thought
- internal mammary lymph nodes
- internal radiation therapy
- International Unit
- internist
- interstitial radiation therapy
- intervention
- intervention group
- intra-arterial
- intracarotid infusion
- intradermal
- intraductal breast papilloma
- intraductal carcinoma
- intrahepatic
- intrahepatic infusion
- intramuscular
- intramuscular injection
- intraoperative radiation therapy
- intraoperative ultrasound
- intratumoral
- intravasation
- intravenous
- intravenous infusion
- intravenous injection
- intrusive thought
- intrusive thoughts
- invasive breast cancer
- invasive cancer
- invasive procedure
- investigational
- investigator
- ionizing radiation
- ipsilateral
- IRB
- irradiated
- irradiation
- irreversible toxicity
- ixabepilone
- joint pain
- Karnofsky Performance Status
- laboratory test
- lapatinib
- laser
- laser surgery
- laser therapy
- lassitude
- late effects
- late-stage cancer
- latent
- laxative
- LEEP
- legal aid organization
- lesion
- lethargy
- letrozole
- leukopenia
- levels of evidence
- Lexapro
- libido
- lidocaine
- ligation
- linac
- linear accelerator
- lipoma
- lisofylline
- liver metastasis
- liver scan
- living will
- lobaplatin
- lobe
- lobectomy
- lobular carcinoma
- lobular carcinoma in situ
- lobule
- local anesthesia
- local cancer
- local therapy
- localization
- localized
- locally advanced cancer
- locally recurrent cancer
- lomustine
- loop electrosurgical excision procedure
- loop excision
- lorazepam
- low grade
- lubricant
- lumbar puncture
- lumpectomy
- lung metastasis
- luteinizing hormone-releasing hormone agonist
- lymph
- lymph gland
- lymph node
- lymph node dissection
- lymph node drainage
- lymph node mapping
- lymph vessel
- lymphadenectomy
- lymphadenopathy
- lymphangiogram
- lymphangiography
- lymphatic basin
- lymphatic fluid
- lymphatic mapping
- lymphatic system
- lymphatic vessel
- lymphedema
- lymphography
- lymphoscintigraphy
- Lyrica
- lytic lesion
- macrocalcification
- magnetic resonance imaging
- magnetic resonance perfusion imaging
- magnetic resonance spectroscopic imaging
- mainstream medicine
- maintenance therapy
- male breast cancer
- malignancy
- malignant
- malignant pleural effusion
- malnutrition
- mammary
- mammary dysplasia
- mammary gland
- mammogram
- mammography
- MammoSite
- Mammotome
- mantle field
- MAO inhibitor
- margin
- marker
- mass
- massage therapy
- mastectomy
- mastitis
- maternal
- maximum tolerated dose
- mean survival time
- measurable disease
- medial supraclavicular lymph node
- median
- median survival time
- Medicaid
- medical castration
- medical device
- medical nutrition therapy
- medical oncologist
- Medicare
- medicine
- medullary breast carcinoma
- mega-voltage linear accelerator
- megestrol
- melphalan
- meningeal metastasis
- menopause
- menorrhagia
- menstrual cycle
- menstrual period
- menstruation
- mental health
- mental health counselor
- meridian
- mesna
- meta-analysis
- metallic
- metastasectomy
- metastasis
- metastasize
- metastatic
- methotrexate
- metoclopramide
- metronomic therapy
- microcalcification
- micrometastasis
- microscopic
- milk duct
- mind/body exercise
- mindfulness relaxation
- Miraluma test
- mitigate
- modified radical mastectomy
- molecular marker
- molecular medicine
- molecular risk assessment
- molecularly targeted therapy
- monoamine oxidase inhibitor
- monoclonal antibody
- morbidity
- mortality
- MRI
- MRSI
- MTD
- mTOR
- mucositis
- multicenter study
- multicentric breast cancer
- multidisciplinary
- multidisciplinary opinion
- multidrug resistance
- multidrug resistance inhibition
- multifocal breast cancer
- music therapy
- mutation
- mutation carrier
- myalgia
- myelosuppression
- nanoparticle paclitaxel
- narcotic
- National Cancer Institute
- National Center for Complementary and Alternative Medicine
- National Institutes of Health
- natural history study
- naturopathy
- nausea
- NCCAM
- NCI
- NCI clinical trials cooperative group
- needle biopsy
- needle localization
- needle-localized biopsy
- negative axillary lymph node
- negative test result
- neoadjuvant therapy
- neoplasm
- nerve
- nerve block
- neurocognitive
- neurologic
- neuropathy
- neurotoxicity
- neurotoxin
- neutropenia
- NIH
- nipple
- nipple discharge
- nitrosourea
- NMRI
- node-negative
- node-positive
- nodule
- nonblinded
- nonconsecutive case series
- noninvasive
- nonmalignant
- nonmetastatic
- nonprescription
- nonrandomized clinical trial
- nonsteroidal anti-inflammatory drug
- nonsteroidal aromatase inhibitor
- nontoxic
- normal range
- normative
- NP
- NPO
- NSAID
- nuclear grade
- nuclear magnetic resonance imaging
- nuclear medicine scan
- nurse
- nurse practitioner
- nutrition
- nutrition therapy
- nutritional counseling
- nutritional status
- nutritional supplement
- nutritionist
- obese
- objective improvement
- objective response
- observation
- observational study
- obstruction
- off-label
- olaparib
- oncologist
- oncology
- oncology nurse
- oncology pharmacy specialist
- oncolysis
- ondansetron
- onset of action
- oophorectomy
- open biopsy
- open label study
- open resection
- operable
- opiate
- opioid
- opportunistic infection
- oral
- organ
- orthodox medicine
- osteolytic
- osteonecrosis of the jaw
- osteopenia
- osteoporosis
- OTC
- out of network
- outcome
- outpatient
- ovarian
- ovarian ablation
- ovarian cancer
- ovarian suppression
- ovary
- over-the-counter
- overall survival rate
- overdose
- overexpress
- overweight
- ovulation
- PA
- paclitaxel
- paclitaxel albumin-stabilized nanoparticle formulation
- paclitaxel-loaded polymeric micelle
- Paget disease of the nipple
- pain threshold
- palliation
- palliative care
- palliative therapy
- palmar-plantar erythrodysesthesia
- palonosetron hydrochloride
- palpable disease
- palpation
- palpitation
- pamidronate
- panic
- papillary tumor
- Paraplatin
- parenteral nutrition
- paroxetine hydrochloride
- PARP
- PARP inhibitor
- partial-breast irradiation
- partial mastectomy
- partial oophorectomy
- partial remission or partial response
- pastoral counselor
- paternal
- pathologic fracture
- pathological stage
- pathological staging
- pathologist
- pathology report
- patient advocate
- Paxil
- peau d'orange
- pedigree
- peer-review process
- peer-reviewed scientific journal
- perfusion magnetic resonance imaging
- perimenopausal
- periodic neutropenia
- perioperative
- peripheral neuropathy
- peripheral venous catheter
- personal health record
- personal medical history
- personalized medicine
- Pertuzumab
- PET scan
- pharmacist
- phase I/II trial
- phase I trial
- phase II/III trial
- phase II trial
- phase III trial
- phase IV trial
- phlebotomy
- photon beam radiation therapy
- phyllodes tumor
- physical examination
- physical therapist
- physical therapy
- physician
- physician assistant
- physiologic
- PI3 kinase inhibitor
- pilocarpine
- pilot study
- placebo
- placebo-controlled
- plastic surgeon
- plastic surgery
- population study
- positive axillary lymph node
- positive test result
- positron emission tomography scan
- post-traumatic stress disorder
- postmenopausal
- postoperative
- postremission therapy
- potentiation
- power of attorney
- PR
- PR+
- PR-
- practitioner
- preauthorization
- precancerous
- preclinical study
- predictive factor
- pregabalin
- premalignant
- premature menopause
- premenopausal
- premium
- prescription
- prevention
- preventive
- preventive mastectomy
- primary care
- primary care doctor
- primary endpoint
- primary therapy
- primary treatment
- primary tumor
- Principal investigator
- prochlorperazine
- progesterone
- progesterone receptor
- progesterone receptor-negative
- progesterone receptor-positive
- progesterone receptor test
- progestin
- prognosis
- prognostic factor
- progression
- progression-free survival
- progressive disease
- Prolia
- proliferative index
- promegapoietin
- prophylactic
- prophylactic mastectomy
- prophylactic oophorectomy
- prophylactic surgery
- prophylaxis
- prospective
- prospective cohort study
- prosthesis
- protective factor
- protein
- protein-bound paclitaxel
- protein expression
- protein expression profile
- protocol
- proton
- proton magnetic resonance spectroscopic imaging
- pruritus
- psychiatrist
- psychological
- psychologist
- psychosocial
- psychotherapy
- PTSD
- pump
- punch biopsy
- qi
- qigong
- quadrantectomy
- quality assurance
- quality of life
- radiation
- radiation brachytherapy
- radiation dermatitis
- radiation fibrosis
- radiation necrosis
- radiation nurse
- radiation oncologist
- radiation physicist
- radiation surgery
- radiation therapist
- radiation therapy
- radical lymph node dissection
- radical mastectomy
- radioactive
- radioactive drug
- radioactive seed
- radioisotope
- radiologic exam
- radiologist
- radiology
- radionuclide
- radionuclide scanning
- radiopharmaceutical
- radiosensitization
- radiosensitizer
- radiosurgery
- radiotherapy
- raloxifene
- raloxifene hydrochloride